Important problems in the diagnosis and treatment of autoimmune hepatitis (based on the Russian consensus 2017)
- 作者: Vinnitskaya E1, Sandler Y.1, Bakulin I2, Parfenov A1, Ilchenko L3, Nikitin I3, Bueverov A4, Lopatkina T4, Ignatova T4, Syutkin V5, Raikhelson K6, Khomeriki S1, Gudkova R1
-
隶属关系:
- S.A. Loginov Moscow Clinical Research and Practical Center, Moscow Healthcare Department
- I.I. Mechnikov North-Western state medical University Ministry of Health of Russia
- N.I. Pirogov Russian National Research Medical University Ministry of Health of Russia
- I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenovskiy University)
- N.V. Sklifosovskiy Research Institute of Emergency Medicine
- Saint Petersburg state University
- 期: 卷 90, 编号 2 (2018)
- 页面: 12-18
- 栏目: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32798
- DOI: https://doi.org/10.26442/terarkh201890212-18
- ID: 32798
如何引用文章
全文:
详细
作者简介
E Vinnitskaya
S.A. Loginov Moscow Clinical Research and Practical Center, Moscow Healthcare Departmentд.м.н., зав. отд. гепатологии МКНЦ им. А.С. Логинова
Yu Sandler
S.A. Loginov Moscow Clinical Research and Practical Center, Moscow Healthcare Department
Email: sandlerjulia2012@gmail.com
к.м.н., с.н.с. гепатологического отд. МКНЦ им. А.С. Логинова
I Bakulin
I.I. Mechnikov North-Western state medical University Ministry of Health of Russiaд.м.н., проф., СЗГМУ им. И.И. Мечникова
A Parfenov
S.A. Loginov Moscow Clinical Research and Practical Center, Moscow Healthcare Departmentд.м.н., проф., зав. отд. патологии кишечника МКНЦ им. А.С. Логинова
L Ilchenko
N.I. Pirogov Russian National Research Medical University Ministry of Health of Russiaд.м.н., проф., РНИМУ им. Н.И. Пирогова
I Nikitin
N.I. Pirogov Russian National Research Medical University Ministry of Health of Russiaд.м.н., проф., РНИМУ им. Н.И. Пирогова
A Bueverov
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenovskiy University)д.м.н., проф., Первый МГМУ им. И.М. Сеченова
T Lopatkina
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenovskiy University)к.м.н., доц., Первый МГМУ им. И.М. Сеченова
T Ignatova
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenovskiy University)
V Syutkin
N.V. Sklifosovskiy Research Institute of Emergency Medicineд.м.н., проф., НИИ СП им. Н.В. Склифосовского
K Raikhelson
Saint Petersburg state Universityд.м.н., проф., СПбГУ
S Khomeriki
S.A. Loginov Moscow Clinical Research and Practical Center, Moscow Healthcare Departmentд.м.н., проф., зав. лаб. патоморфологии МКНЦ им. А.С. Логинова
R Gudkova
S.A. Loginov Moscow Clinical Research and Practical Center, Moscow Healthcare Departmentд.м.н., с.н.с. лаб. научно-диагностических исследований МКНЦ им. А.С. Логинова
参考
- Ивашкин В.Т., Буеверов А.О., Маевская М.В., Абдулганиева Д.И. Клинические рекомендации по диагностике и лечению аутоиммунного гепатита. Российская Гастроэнтерологическая Ассоциация. Российское общество по изучению печени; 2013. Доступно по ссылке: http://www.gastro.ru/?pageId=41. Ссылка активна на 15.07.2017.
- European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol. 2015;63:971-1004. doi: 10.1016/j.jhep.2015.09.016
- Manns M.P, Czaja A.J, Gorham J.D, Krawitt E.L, Mieli-Vergani G, Vergani D, Vierling J.M. Diagnosis and Management of Autoimmune Hepatitis. AASLD Practice Guidelines. Hepatology. 2010;51(6):2193-213. doi: 10.1002/hep.23584
- Gleeson D, Heneghan M.A. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut. 2011;60:1611-29. doi: 10.1136/gut.2010.235259
- Буеверов А.О. Серонегативный аутоиммуный гепатит. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2017;27(2):27-33. doi: 10.22416/1382-4376-2017-27-2-27-33.
- Dienes H.P, Erberich H, Dries V, Schirmacher P, Lohse A. Autoimmune hepatitis and overlap syndromes. Clin Liver Dis. 2002;6:349-62.
- Czaja A.J, Carpenter H.A. Autoimmune hepatitis with incidental histologic features of bile duct injury. Hepatology. 2001;34:659-65.
- Zen Y, Notsumata K, Tanaka N, Nakanuma Y. Hepatic centrilobular zonal necrosis with positive antinuclear antibody: a unique subtype or early disease of autoimmune hepatitis? Hum Pathol. 2007;38:1669-75. doi: 10.1016/j.humpath.2007.03.019
- Hofer H, Oesterreicher C, Wrba F, Ferenci P, Penner E. Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation. J Clin Pathol. 2006;59:246-9. doi: 10.1136/ jcp.2005.029348
- Loria P, Lonardo A, Leonardi F, Fontana C, Carulli L, Verrone A.M, et al. Non - organ - specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig Dis Sci. 2003;48:2173-81.
- Cotler S.J, Kanji K, Keshavarzian A, Jensen D.M, Jakate S. Prevalence and significance of autoantibodies in patients with non - alcoholic steatohepatitis. J Clin Gastroenterol. 2004;38:801-4.
- Wiegard C, Schramm C, Lohse A.W. Scoring systems for the diagnosis of autoimmune hepatitis: past, present, and future. Semin Liver Dis. 2009;29:254-61. doi: 10.1002/hep.22322
- Luth S, Weiler-Normann C, Schramm C, Lohse A.W. Autoimmune liver diseases. Internist (Berl). 2009;50:310-7. doi: 10.1007/s001
- Verma S, Gunuwan B, Mendler M, Govindrajan S, Redeker A. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy. Am J Gastroenterol. 2004;99(8):1510-6.
- Luth S, Herkel J, Kanzler S, Frenzel C, Galle P.R, Dienes H.P, Schramm C, Lohse A.W. Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis. J Clin Gastroenterol. 2008;42(8):926-30. doi: 10.1097/mcg.0b013e318154af74
- Czaja A.J. Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions. Gut Liver. 2016;10(2):177-203. doi: 10.5009/gnl15352
- Lohse A.W, Mieli-Vergani G. Autoimmune hepatitis. J Hepatol. 2011;55(1):171-82. doi: 10.1016/j.jhep.2010.12.012
- Feld J.J, Dinh H, Arenovich T, Marcus V.A, Wanless I.R, Heathcote E.J. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology. 2005;42:53-62. doi: 10.1002/hep.20732
- Dufour J.F, Zimmermann M, Reichen J. Severe autoimmune hepatitis in patients with previous spontaneous recovery of a flare. J Hepatol. 2002;37:748-52.
- Czaja A.J. Features and consequences of untreated type 1 autoimmune hepatitis. Liver Int. 2009;29:816-23. doi: 10.1111/j.1478-3231. 2008.01904.x
- Kogan J, Safadi R, Ashur Y, Shouval D, Ilan Y. Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients. J Clin Gastroenterol. 2002;35:75-81.
- Лопаткина Т.Н. Аутоиммунный гепатит и перекрестные синдромы Фарматека. 2010;15(209):62-8.
- Manns M.P, Woynarowski M, Kreisel W, Lurie Y, Rust C, Zuckerman E, Bahr M.J, Günther R, Hultcrantz R.W, Spengler U, et al. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Gastroenterology. 2010; 139:1198-206. doi: 10.1053/j.gastro.2010.06.046
- Woynarowski M, Nemeth A, Baruch Y, Koletzko S, Melter M, Rodeck B, Strassburg CP, Prоls M, Woźniak M, Manns MP. Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents. J Pediatr. 2013;163:1347-453. doi: 10.1016/j.jpeds.2013.05.042
- Manns M.P, Bahr M.J, Woynarowski M, Kreisel W, Oren R, Gunther R, Hultcrantz R, Proels M, Rust C, Spengler U, et al. Budesonide 3 mg tid is superior to prednisone in combination with azathioprine in the treatment of autoimmune hepatitis. J Hepatol. 2008;2:369. doi: 10.1016/ S0168-8278(08)60991-5
- Manns M.P, Strassburg C.P. Therapeutic strategies for autoimmune hepatitis. Dig Dis. 2011;29(4):411-5. doi: 10.1159/000329805
- Czaja A.J. Special clinical challenges in autoimmune hepatitis: the elderly, males, pregnancy, mild disease, fulminant onset, and nonwhite patients. Semin Liver Dis. 2009;29:315-30. doi: 10.1055/s-0029-1233530
- Czaja A.J, Carpenter H.A. Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly. Hepatology. 2006;43:532-8.
- Czaja A.J. Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly. Drugs Aging. 2008;25:219-39. doi: 10.2165/00002512-200825030-00005
- Al-Chalabi T, Boccato S, Portmann B.C, Mc Farlane I.G, Heneghan M.A. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol. 2006;45:575-83. doi: 10.1016/j.jhep.2006.04.007
- Strassburg C.P, Manns M.P. Autoimmune hepatitis in the elderly: What is the difference? J Hepatol. 2006;45(4):480-2. doi: 10.1016/ j.jhep.2006.07.008
- Terrabuio D.R, Abrantes-Lemos C.P, Carrilho F.J, Cancado E.L. Follow - up of pregnant women with autoimmune hepatitis: the disease behavior along with maternal and fetal outcomes. J Clin Gastroenterol. 2009;43:350-6. doi: 10.1097/MCG.0b013e318176b8c5
- Schramm C, Herkel J, Beuers U, Kanzler S, Galle P.R, Lohse A.W. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol. 2006;101:556-60. doi: 10.1111/j.1572-0241.2006. 00479.x
- Westbrook R.H, Yeoman A.D, Kriese S, Heneghan M.A. Outcomes of pregnancy in women with autoimmune hepatitis. J Autoimmun. 2012;38:239-44. doi: 10.1016/j.jaut.2011.12.002
- Buchel E, van Steenbergen W, Nevens F, Fevery J. Improvement of autoimmune hepatitis during pregnancy followed by flare - up after delivery. Am J Gastroenterol. 2002;97:3160-5. doi: 10.1016/s0002-9270(02)05541-7
- Braga A.C, Vasconcelos C, Braga J. Pregnancy with autoimmune hepatitis. Gastroenterol Hepatol Bed Bench. 2016;9(3):224. doi: 10.1136/bcr-2015-212501
- De Boer N.K, Jarbandhan S.V, de Graaf P, Mulder C.J, van Elburg R.M, van Bodegraven A.A. Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. Am J Gastroenterol. 2006;101:1390-2. doi: 10.1111/j.1572-0241.2006.00538
- Hviid A, Molgaard-Nielsen D. Corticosteroid use during pregnancy and risk of orofacial clefts. Can Med Assoc J. 2011 Apr 19;183(7):796-804. doi: 10.1503/cmaj.101063
- Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present D.H. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology. 2003;124:9-17. doi: 10.1053/gast.2003.50014
- Werner M, Bjоrnsson E, Prytz H. Autoimmune hepatitis among fertile women: strategies during pregnancy and breast - feeding? Scand J Gastroenterol. 2007;42:986-91. doi: 10.1080/00365520601155266
- Akbari M, Shah S, Velayos F.S, Mahadevan U, Cheifetz A.S. Systematic review and meta - analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:15-22. doi: 10.1002/ibd.22948
- Casanova M.J, Chaparro M, Domеnech E. Safety of thiopurines and anti-TNF-alpha drugs during pregnancy in patients with inflammatory bowel disease. Am J Gastroenterol. 2013;108:433-40. doi: 10.1038/ajg.2012.430
- Candia L, Marquez J, Espinoza L.R. Autoimmune hepatitis and pregnancy: a rheumatologist’s dilemma. Semin Arthritis Rheum. 2005;35:49-56.
- Bar J, Stahl B, Hod M, Wittenberg C, Pardo J, Merlob P. Is immunosuppression therapy in renal allograft recipients teratogenic? A single - center experience. Am J Med Genet A. 2003;116(1):31-6. doi: 10.1002/ajmg.a.10817
- Natekar A, Pupco A, Bosso P, Koren G. Safety of azathioprine use during pregnancy. Can Fam Phys. 2011;57(12):1401-2.
- Naqvi R, Noor H, Ambareen S, Khan H, Haider A, Jafri N, et al. Outcome of pregnancy in renal allograft recipients: SIUT experience. Transplant Proc. 2006;38(7):2001-2. doi: 10.1016/j.transproceed. 2006.06.020
- Heneghan M.A, Norris S.M, O’Grady J.G, Harrison P.M, Mc Farlane I.G. Management and outcome of pregnancy in autoimmune hepatitis. Gut. 2001;48:97-102.
- Goldstein L.H, Dolinsky G, Greenberg R, Schaefer C, Cohen-Kerem R, Diav-Citrin O, Malm H, Reuvers-Lodewijks M.E, Rost van Tonningen - van Driel M.M, Arnon J, Ornoy A, Clementi M, Di Gianantonio E, Koren G, Braunstein R, Berkovitch M. Pregnancy outcome of women exposed to azathioprine during pregnancy. Birth Defects Res A Clin Mol Teratol. 2007 Oct;79(10):696-701.
- Hutson J.R, Matlow J.N, Moretti M.E, Koren G. The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy. J Obstet Gynaecol. 2012;33(1):1-8. doi: 10.3109/01443615. 2012.716106